All Times EDT
Keywords: justice, equity, diversity, inclusion, clinical trials
Join us in a follow-up roundtable discussion from last year, as we continue to build and share our understanding of the current state of justice, equity, diversity, and inclusion (JEDI) in the industry, what areas need growth, and how we as members of the statistical community can contribute to achieve that growth. No expertise required. All are welcomed who are passionate to see greater JEDI achieved, be it from the perspective of a patient, regulatory/pharmaceutical statistician, or others.